The Department of Health and Human Services and other federal agencies should work through the Biodefense Steering Committee to ensure the Biodefense Coordination Team defines the capabilities needed to prepare for and respond to significant biological incidents such as COVID-19; monitors and reports on findings from interagency exercises and real-world incidents; and recommends action to address identified challenges, according to a report released today by the Government Accountability Office. The Coronavirus Aid, Relief, and Economic Security Act called for GAO to review federal efforts to prepare for, respond to and recover from COVID-19. The agency reviewed interagency response plans and exercises and real biological incidents between 2009 and 2019 to identify opportunities to better achieve National Biodefense Strategy objectives.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…